Insider buying
~$24K8,000 sh @ $2.98
Traded Oct 23 · filed 3 days later
An Anixa Biosciences director paid $24K out of pocket for Anixa Biosciences shares. 3 other people at Anixa Biosciences bought some too, in the same month.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Oct 30, 2026 · Filed Nov 2, 2026
The CEO of Anixa Biosciences paid $16K out of pocket for Anixa Biosciences shares. 2 other people at Anixa Biosciences bought some too, in the same month.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$15,850
Shares × reported transaction price
<$25K
+0.7%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 15 earlier confirmed purchases
3 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
This purchase equals less than 1% of the CEO's reported total pay for fiscal 2025 ($2.55M)
Purchase value ÷ the CEO's total from the Summary Compensation Table, as tagged in the pay versus performance table of the company's proxy statement (DEF 14A), filed 2026-01-28. The proxy names Dr. Kumar as CEO for that year. A size comparison, not a judgement
Closed at $3.12 on Oct 30, 2026, 33% above its 52-week low and 40% below its high, after a 13% rise over the previous 30 trading days
52-week range $2.35 (Jun 10, 2026) to $5.22 (Dec 8, 2025), 27% of the way up, from 251 adjusted closes. 30 trading days earlier: $2.77 on Sep 18, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.2% | −0.6% | +0.8% |
Past results only. Not a forecast.
Insider buying
Traded Oct 23 · filed 3 days later
An Anixa Biosciences director paid $24K out of pocket for Anixa Biosciences shares. 3 other people at Anixa Biosciences bought some too, in the same month.
Insider buying
Traded Oct 22 · filed the same day
The CEO of Anixa Biosciences paid $22K out of pocket for Anixa Biosciences shares. 3 other people at Anixa Biosciences bought some too, in the same month.
Insider buying
3 insiders in a week, 16th time since 2006Traded Sep 30 · filed the same day
The CFO of Anixa Biosciences paid $16K out of pocket for Anixa Biosciences shares. 3 other people at Anixa Biosciences bought some too, in the same month. It was the first purchase in 20 months.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Amit Kumar, Chief Executive Officer's past purchases, 90 days after disclosure: 10 buys, median −6.0 pts vs S&P 500, beat it 3 of 10 times. Past results, not a forecast.